Specific Binding of a Hela Cell Nuclear Protein to RNA Sequences in The

Total Page:16

File Type:pdf, Size:1020Kb

Specific Binding of a Hela Cell Nuclear Protein to RNA Sequences in The Proc. Nati. Acad. Sci. USA Vol. 86, pp. 4858-4862, July 1989 Biochemistry Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region (chemical nuclease imprinting/untranslated RNA binding protein 1) RICHARD GAYNOR*tt, EMMANUEL SOULTANAKIS*t, MICHIo KUWABARA*§, JOSEPH GARCIA*t, AND DAVID S. SIGMAN*§ *Molecular Biology Institute, and tDivision of Hematology-Oncology, Department of Medicine, and §Department of Biological Chemistry, School of Medicine, and tWadsworth Veterans Hospital, University of California, Los Angeles, CA 90024 Communicated by Paul D. Boyer, March 27, 1989 ABSTRACT The transactivator protein, tat, encoded by been shown to be involved in increasing the steady-state level the human immunodeficiency virus is a key regulator of viral of RNA, it has also been reported to increase the translation transcription. Activation by the tat protein requires sequences of RNA (15, 17, 22). The possibility that increased levels of downstream of the transcription initiation site called the trans- RNA are attributable to an antitermination mechanism has activating region (TAR). RNA derived from the TAR is capable also been raised (5, 18-20, 27). In contrast to other transac- offorming a stable stem-oop structure and the maintenance of tivating proteins, such as ElA (28), which activate a number both the stem structure and the loop sequences located between of viral and cellular promoters, tat activation is specific for + 19 and +44 is required for complete in vivo activation by tat. the HIV LTR. It is of interest to identify features ofthe TAR Gel retardation assays with RNA from both wild-type and responsible for this selectivity. mutant TAR constructs generated in viro with SP6 polymerase Since TAR RNA secondary structure appeared to be one indicated specific binding ofHeLa nuclear proteins to the TAR. component required for complete activation by the tat pro- To characterize this RNA-protein interaction, a method of tein, the possibility that a cellular protein may mediate the chemical "imprinting" has been developed using photoacti- interaction of tat with TAR RNA has been explored. The vated uranyl acetate as the nucleolytic agent. This reagent nicks methods used were gel-retardation analysis (29) and a new RNA under physiological conditions at all four nucleotides in a method of examining RNA-protein interactions in which reaction that is independent of sequence and secondary struc- light-activated uranyl acetate is used as the nucleolytic agent. ture. Specific interaction of cellular proteins with TAR RNA This reagent, which was previously shown to cut DNA in a could be detected by enhanced cleavages or imprints surround- sequence-independent reaction (30), cleaves RNA in a pri- ing the loop region. Mutations that either disrupted stem mary and secondary structure-independent manner under base-pairing or extensively changed the primary sequence physiological conditions. Both methods demonstrate specific resulted in alterations in the cleavage pattern ofthe TAR RNA. binding of a HeLa nuclear protein which we designate as Structural features ofthe TAR RNA stem-oop essential for tat untranslated RNA binding protein 1 (URBP-1) to TAR RNA. activation are also required for specific binding ofthe HeLa cell nuclear protein. MATERIALS AND METHODS Plasmid Constructs and Labeling of mRNAs. Wild-type and Gene expression of the human immunodeficiency virus mutant HIV mRNAs shown in Fig. 1 were constructed by (HIV) is dependent on multiple cis-acting sequences in the taking a Pvu II/Xho I fragment (-18 to +80) from pJGFCAT long terminal repeat (LTR) which serve as the binding sites derivatives (10) and inserting them into a pGEM derivative in for cellular proteins that are important in viral gene regulation which the Pst I site was converted into an Xho I site by linker (1-13). In addition, at least three viral proteins-tat, rev, and insertion. Each pGEM construct was digested with HindIII, nef-are also involved in modulating gene expression (14- and RNA synthesis, labeling, and purification were per- 26). One of these HIV-encoded proteins, tat, requires for its formed using the reagents and procedures of the Riboprobe action a region of the HIV LTR extending from -17 to +80, System II (Promega) (29). known as the transactivating region (TAR) (1, 5-10). Gel Retardation Assays and Chemical Footprinting of RNA. TAR sequences may be involved in tat regulation of HIV Gel retardation assays were performed as described by transcription at both the DNA and RNA levels. For example, Leibold and Munro (29). Internally labeled mRNA (50,000 it is the recognition site for cellular DNA binding proteins cpm) was incubated with 1-5 ,ug ofa heparin-agarose column- UBP-1 (12) and UBP-2 (10) (UBP, untranslated binding purified HeLa nuclear extract (31) in 10 ,ul for 20 min (5, 30). protein). Mutagenesis of multiple UBP-1 binding sites in the When included, 1 pmol ofthe indicated unlabeled competitor TAR resulted in decreased activation by the tat protein in mRNA was addedjust prior to the addition oflabeled mRNA. transient gene expression assays with the HIV LTR (9, 10). For chemical cleavage, RNA was 5'-end-labeled (100,000 On the other hand, RNA from the TAR is capable offorming cpm) and incubated as in the gel retardations except 50 mM a stable stem-loop structure (4). Mutagenesis of the TAR NaCl was used instead of 100 mM NaCl and reaction volumes indicated that maintenance ofstem base-pairing between +19 were 100 1.L. Then, 10 Jud of 20 mM uranyl acetate was added and +44 was critical for tat activation (6, 10). However, the followed by exposure to short-wave UV light (7000 p.W/cm2) primary sequence of the loop region between +28 and +34 for 30 min. RNA was extracted, ethanol precipitated, and was also critical for this activation (6, 10). loaded onto a 10% polyacrylamide sequencing gel. Footprint- The mechanism(s) by which the tat protein activates HIV ing lanes were calibrated with partial ribonuclease T1 digests gene expression is not known. Although the tat protein has and autoradiography was performed. The publication costs of this article were defrayed in part by page charge Abbreviations: HIV, human immunodeficiency virus; LTR, long payment. This article must therefore be hereby marked "advertisement" terminal repeat; TAR, transactivating region; UBP, untranslated in accordance with 18 U.S.C. §1734 solely to indicate this fact. binding protein; URBP-1, untranslated RNA binding protein 1. 4858 Biochemistry: Gaynor et al. Proc. Natl. Acad. Sci. USA 86 (1989) 4859 A G G G G C G G G U G U G U G U G C A C A C A C A C A C - G C- G C - G C - G C - G G - C G- C G - C G - C C - C A -U A - U A - U A - U UA U G- C U U G- C U G- C U G- C U G- C U A- U U A- U US U UA a G- C G - C G- C G - C UG - A.C A - U A - U ~OU A .. C- G C - G C - G m-g - G C - G G C - G - G AC A G- A-C-C AC AG -C C G G- C G - C A- U A- U A - U A- U A - U U - A U - A U - A U - A U- A U - A U - A U - A U - A - G - C G C G - C G - C G - C G*U G U CG U G.U U - A U - A U - A U - A U - A C - G C - G C - G C - G C - G U*G U*G U .G U G U G C - G C - G C - G C - G C - G U - A - U- A C C U -A C U U-A C U - A U - A U - A U - A C U - A G - C G - C G - C G - C G - C - G - C G C G - C G - C G - C m GpppG- CACU GpppG- CACU m GpppG- CACU m GpppGC CACU GpppG- CACU +1 +62 +1 +62 +1 +62 +1 +62 +1 +62 WT(+80) [+31/+34] [+19/+22] [+40/+43] 1+19/+22]/[+40/+43] B (; ( (; (; C U G U G C A C A C A C- (; G - C G - C (;-C A- U AJ-UA U A-U C-G U CCA U A-U C U A- U C-C AA-U;^-U A-U A-U C-GC C -(; C - C- G A A' G- C G-C C -C A- A-U A-U U (; - C U'-AU-AG- C U-A U-A C - C C-G C-A-G2G A-U FIG. 1. Secondary structure ofTAR C-G :h-U C-C U-A: mutants. RNA transcribed from the UF C U-A C -G TARwith stem base pairingand the loop region are shown. (A) Wild type and C U GCCCUl mutants [+31/+34], [+19/+22], [+40/ UA U-A +43], and [+19/+22]/[+40/+43] are in- C-CG-C G-C C-C dicated. (B) Wild type and mutants G-C C-C ATAR-sense and ATAR-antisense are m Gppp G G mCppp G G mCppp G C indicated. The sequencefrom +1 to +62 +1 +59 +1 +60 +1 +60 in each construct is shown and the po- sitions ofthe mutations are indicated by WT(ATAR) ATAR-Sense ATAR-Antisense the shaded regions. RESULTS extract (Fig. 2A). This species specifically competed with a Gel-Retardation Analysis of Wild-Type and Mutant TAR 50-fold excess of unlabeled wild-type RNA, but not with a RNAs.
Recommended publications
  • Site-Selective Artificial Ribonucleases: Renaissance of Oligonucleotide Conjugates for Irreversible Cleavage of RNA Sequences
    molecules Review Site-Selective Artificial Ribonucleases: Renaissance of Oligonucleotide Conjugates for Irreversible Cleavage of RNA Sequences Yaroslav Staroseletz 1,†, Svetlana Gaponova 1,†, Olga Patutina 1, Elena Bichenkova 2 , Bahareh Amirloo 2, Thomas Heyman 2, Daria Chiglintseva 1 and Marina Zenkova 1,* 1 Laboratory of Nucleic Acids Biochemistry, Institute of Chemical Biology and Fundamental Medicine SB RAS, Lavrentiev’s Ave. 8, 630090 Novosibirsk, Russia; [email protected] (Y.S.); [email protected] (S.G.); [email protected] (O.P.); [email protected] (D.C.) 2 School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Rd., Manchester M13 9PT, UK; [email protected] (E.B.); [email protected] (B.A.); [email protected] (T.H.) * Correspondence: [email protected]; Tel.: +7-383-363-51-60 † These authors contributed equally to this work. Abstract: RNA-targeting therapeutics require highly efficient sequence-specific devices capable of RNA irreversible degradation in vivo. The most developed methods of sequence-specific RNA cleav- age, such as siRNA or antisense oligonucleotides (ASO), are currently based on recruitment of either intracellular multi-protein complexes or enzymes, leaving alternative approaches (e.g., ribozymes Citation: Staroseletz, Y.; Gaponova, and DNAzymes) far behind. Recently, site-selective artificial ribonucleases combining the oligonu- S.; Patutina, O.; Bichenkova, E.; cleotide recognition motifs (or their structural
    [Show full text]
  • Electronic Supplementary Material (ESI) for Green Chemistry. This Journal Is © the Royal Society of Chemistry 2016
    Electronic Supplementary Material (ESI) for Green Chemistry. This journal is © The Royal Society of Chemistry 2016 Electronic Supplementary Information for: Lignin depolymerization by fungal secretomes and a microbial sink† Davinia Salvachúaa,‡, Rui Katahiraa,‡, Nicholas S. Clevelanda, Payal Khannaa, Michael G. Rescha, Brenna A. Blacka, Samuel O. Purvineb, Erika M. Zinkb, Alicia Prietoc, María J. Martínezc, Angel T. Martínezc, Blake A. Simmonsd,e, John M. Gladdend,f, Gregg T. Beckhama,* a. National Bioenergy Center, National Renewable Energy Laboratory (NREL), Golden CO 80401, USA b. Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory (PNNL), Richland, WA 99352, USA c. Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), E-28040 Madrid, Spain d. Joint BioEnergy Institute (JBEI), Emeryville, CA 94608 e. Biological Systems and Engineering, Lawrence Berkeley National Laboratory, Berkeley CA 94720 USA f. Sandia National Laboratory, Livermore CA 94550 ‡ Equal contribution * Corresponding author: [email protected] Extension of materials and methods section Analysis of aromatics by LC-MS/MS Mass spectrometry was used in the last experiment of the current study to analyze aromatics from the soluble fraction. For this purpose, 14.5 mg of freeze-dried supernatant from 8 different treatments was reconstituted in 1 mL methanol. Analysis of samples was performed on an Agilent 1100 LC system equipped with a diode array detector (DAD) and an Ion Trap SL MS (Agilent Technologies, Palo Alto, CA) with in-line electrospray ionization (ESI). Each sample was injected at a volume of 25 μL into the LC-MS system. Primary degradation compounds were separated using a YMC C30 Carotenoid 0.3 μm, 4.6 x 150 mm column (YMC America, Allentown, PA) at an oven temperature of 30°C.
    [Show full text]
  • The Characterization of Oligonucleotides and Nucleic Acids Using Ribonuclease H and Mass Spectrometry
    Louisiana State University LSU Digital Commons LSU Historical Dissertations and Theses Graduate School 1999 The hC aracterization of Oligonucleotides and Nucleic Acids Using Ribonuclease H and Mass Spectrometry. Lenore Marie Polo Louisiana State University and Agricultural & Mechanical College Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses Recommended Citation Polo, Lenore Marie, "The hC aracterization of Oligonucleotides and Nucleic Acids Using Ribonuclease H and Mass Spectrometry." (1999). LSU Historical Dissertations and Theses. 6923. https://digitalcommons.lsu.edu/gradschool_disstheses/6923 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact [email protected]. INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter free, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand corner and continuing from left to right in equal sections with small overlaps.
    [Show full text]
  • Proteomics Reveals Synergy Between Biomass Degrading Enzymes and Inorganic Fenton Chemistry in Leaf-Cutting Ant Colonies Morten Schiøtt*, Jacobus J Boomsma
    RESEARCH ARTICLE Proteomics reveals synergy between biomass degrading enzymes and inorganic Fenton chemistry in leaf-cutting ant colonies Morten Schiøtt*, Jacobus J Boomsma Centre for Social Evolution, Department of Biology, University of Copenhagen, Universitetsparken, Copenhagen, Denmark Abstract The symbiotic partnership between leaf-cutting ants and fungal cultivars processes plant biomass via ant fecal fluid mixed with chewed plant substrate before fungal degradation. Here we present a full proteome of the fecal fluid of Acromyrmex leaf-cutting ants, showing that most proteins function as biomass degrading enzymes and that ca. 85% are produced by the fungus and ingested, but not digested, by the ants. Hydrogen peroxide producing oxidoreductases were remarkably common in the proteome, inspiring us to test a scenario in which hydrogen peroxide reacts with iron to form reactive oxygen radicals after which oxidized iron is reduced by other fecal-fluid enzymes. Our biochemical assays confirmed that these so-called Fenton reactions do indeed take place in special substrate pellets, presumably to degrade plant cell wall polymers. This implies that the symbiotic partnership manages a combination of oxidative and enzymatic biomass degradation, an achievement that surpasses current human bioconversion technology. Introduction *For correspondence: Mutualistic mergers of simpler biological entities into organizationally complex symbioses have been [email protected] key steps in the evolution of advanced synergistic forms of life, but understanding the origins and secondary elaborations of such natural cooperative systems remains a major challenge for evolution- Competing interests: The ary biology (Smith and Szathma´ry, 1997; Bourke, 2011). Physiological complementarity may be a authors declare that no main driver to maintain symbiotic associations, but new adaptations are also expected to jointly competing interests exist.
    [Show full text]
  • The Purification and Characterization of a Ribonuclease from Bovine Aorta
    AN ABSTRACT OF THE THESIS OF ROGER ALLEN LEWIS for the Ph. D. (Name of student) ( Degree) in BIOCHEMISTRY presented on March 28, 1968 (Major) (Date) Title: THE PURIFICATION AND CHARACTERIZATION OF A RIBONUCLEASE FROM BOVINE AORTA Redacted for privacy Abstract approved: Wilbert Gamble Reports of investigations on nucleases in arterial tissue are few in number. The present study is concerned with the purifica- tion and characterization of an aortic ribonuclease. An endonuclease (ARNase I) isolated from the bovine aorta has been purified 4611 fold by means of fractionation with ethanol, acid extraction, isoionic precipitation, BioR ex 70 column chromatography and dialysis. A second fraction from BioR ex 70 column chromato- graphy, ARNase II, was partially purified 667 fold. A pH optimum for ARNase I activity on O. 5% sodium RNA was observed at 7. 5 and no activity was detected at pH 5. 1, The enzyme exhibited a temperature optimum of 60°C. Polyuridylic acid (poly U) was rapidly depolymerized by ARNase I, whereas polycytidylic acid (poly C) was only slowly hy- drolyzed by the enzyme at a rate of 1/24 that exhibited on poly U. Polyguanylic acid, polyadenylic acid and polyinosinic acid were resistant to enzymatic action. ARNase II was 18 times more active on poly C and one -seventh as active on poly U as was ARNase I. Cytidylyl -( 3'- 5')- cytidine and uridylyl- (3'- 5')- cytidine were hydrolized by ARNase I with the products being 2', 3'- cyclic cytidylic acid and cytidine and 2', 3'- cyclic uridylic acid and cytidine, respec- tively. Adenylyl- (3'- 5')- cytidine and guanylyl- (3'- 5')- cytidine were not acted upon by the enzyme.
    [Show full text]
  • Rnase T1 Mimicking Artificial Ribonuclease N
    2356–2367 Nucleic Acids Research, 2007, Vol. 35, No. 7 Published online 27 March 2007 doi:10.1093/nar/gkm143 RNase T1 mimicking artificial ribonuclease N. L. Mironova, D. V. Pyshnyi, D. V. Shtadler, A. A. Fedorova, V. V. Vlassov and M. A. Zenkova* Institute of Chemical Biology and Fundamental Medicine SB RAS, Lavrentiev Ave., 8, Novosibirsk, Russia, 630090 Received December 21, 2006; Revised February 5, 2007; Accepted February 22, 2007 ABSTRACT transesterification reaction [for example, imidazole (9–11), aminogroups (12), guanidinium groups (13)]. aRNases Recently, artificial ribonucleases (aRNases)—con- designed using this approach usually display cleavage jugates of oligodeoxyribonucleotides and peptide specificity similar to that of RNase A: they cleave RNA (LR)4-G-amide—were designed and assessed in predominantly at linkages within Pyr-A motifs, which are terms of the activity and specificity of RNA clea- known to be highly sensitive towards various cleaving vage. The conjugates were shown to cleave RNA at agents (14). These aRNases accelerate cleavage at the Downloaded from Pyr-A and G–X sequences. Variations of oligonu- most sensitive sites within RNA. cleotide length and sequence, peptide and linker The sequence specificity of natural RNases is deter- structure led to the development of conjugates mined by the substrate recognition centre in which the exhibiting G–X cleavage specificity only. The most specific interaction of amino acids with RNA provides efficient catalyst is built of nonadeoxyribonucleo- for the specific binding and placement of a particular http://nar.oxfordjournals.org/ heterocyclic base, thus resulting in the optimal conforma- tide of unique sequence and peptide (LR)4-G-NH2 connected by the linker of three abasic deoxyribo- tion of internucleotide phosphodiester bonds, which are subjected to cleavage.
    [Show full text]
  • Appendix 1: Nonhazardous Chemicals
    Environmental Health & Safety Appendix 1: Nonhazardous Chemicals This list is not all-inclusive. Discharges with a pH between 5.5 and 9.5 Does not contain As, Ba, Cd, Cr, Pb, Hg, Se, Ag, Mn, Ni, Cu, or Zn A-B, C-F, G-L, M-P, R-X A-B Actin A-Adenosine, free base Adenosine 2' & 3'-monophosphate, disodium salt Adenosine 2' & 3'-monophosphate, free acid Adenosine 2',3'-cyclic monophosphate, sodium salt Adenosine 3',5'-cyclic monophosphate, sodium salt Adenosine 3'-monophosphate, sodium salt Adenosine 5'-diphosphate, sodium salt Adenosine 5'-monophosphate Adenosine 5'-monophosphate, disodium salt Adenosine 5'-monophosphate, sodium salt Adonitol; Ribitol Agar; Bacto agar Agarose Alginic acid, sodium salt; Sodium alginate ß-Alanine DL-Alanine L-Alanine Albumin, bovine Albumin, bovine, methylated Albumin, human Alcohol dehydrogenase Aldolase, type X DL-Aminobutyric acid; GABA 4-Amino-2-methyl-1-naphthol; Vitamin K5 Amylase alpha-Amylase, type II-A alpha-Amylase, type VI-B ß-Amylase, sweet potato Amyloglucosidase Amylose Apyrase, grade VI D-Arabinose L(+) Arabinose D-Arabitol Arginase Arginine L-(+)-Arginine D-Asparagine, monohydrate DL-Asparagine L-Asparagine Aspartamene; Asp-phe methyl ester; L-Aspartyl-L-phenylalanine methyl ester D-Aspartic acid DL-Aspartic acid L-Aspartic acid L-Aspartic acid, monosodium salt Autex developer and replenisher Baclofen Bacto peptone; Peptone Base waste (aqueous), neutralized to a pH between 5 and 11.5 (does not contain As, Ba, Cd, Cr, Pb, Hg, Se, Ag, Mn, Ni, Cu, or Zn) Bayberry wax Bentonite ß-Glucuronidase,
    [Show full text]
  • BMC Genomics 2014, 15:535
    Zuleta et al. BMC Genomics 2014, 15:535 http://www.biomedcentral.com/1471-2164/15/535 RESEARCH ARTICLE Open Access The complete genome of Burkholderia phenoliruptrix strain BR3459a, a symbiont of Mimosa flocculosa: highlighting the coexistence of symbiotic and pathogenic genes Luiz Fernando Goda Zuleta1†, Claúdio de Oliveira Cunha2,3†, Fabíola Marques de Carvalho1†, Luciane Prioli Ciapina1, Rangel Celso Souza1, Fábio Martins Mercante4, Sergio Miana de Faria5, José Ivo Baldani5, Rosangela Straliotto5, Mariangela Hungria6 and Ana Tereza Ribeiro de Vasconcelos1* Abstract Background: Burkholderia species play an important ecological role related to xenobiosis, the promotion of plant growth, the biocontrol of agricultural diseases, and symbiotic and non-symbiotic biological nitrogen fixation. Here, we highlight our study as providing the first complete genome of a symbiotic strain of B. phenoliruptrix, BR3459a (=CLA1), which was originally isolated in Brazil from nodules of Mimosa flocculosa and is effective in fixing nitrogen in association with this leguminous species. Results: Genomic comparisons with other pathogenic and non-pathogenic Burkholderia strains grouped B. phenoliruptrix BR3459a with plant-associated beneficial and environmental species, although it shares a high percentage of its gene repertoire with species of the B. cepacia complex (Bcc) and "pseudomallei" group. The genomic analyses showed that the bce genes involved in exopolysaccharide production are clustered together in the same genomic region, constituting part of the Group III cluster of non-pathogenic bacteria. Regarding environmental stresses, we highlight genes that might be relevant in responses to osmotic, heat, cold and general stresses. Furthermore, a number of particularly interesting genes involved in the machinery of the T1SS, T2SS, T3SS, T4ASS and T6SS secretion systems were identified.
    [Show full text]
  • 12) United States Patent (10
    US007635572B2 (12) UnitedO States Patent (10) Patent No.: US 7,635,572 B2 Zhou et al. (45) Date of Patent: Dec. 22, 2009 (54) METHODS FOR CONDUCTING ASSAYS FOR 5,506,121 A 4/1996 Skerra et al. ENZYME ACTIVITY ON PROTEIN 5,510,270 A 4/1996 Fodor et al. MICROARRAYS 5,512,492 A 4/1996 Herron et al. 5,516,635 A 5/1996 Ekins et al. (75) Inventors: Fang X. Zhou, New Haven, CT (US); 5,532,128 A 7/1996 Eggers Barry Schweitzer, Cheshire, CT (US) 5,538,897 A 7/1996 Yates, III et al. s s 5,541,070 A 7/1996 Kauvar (73) Assignee: Life Technologies Corporation, .. S.E. al Carlsbad, CA (US) 5,585,069 A 12/1996 Zanzucchi et al. 5,585,639 A 12/1996 Dorsel et al. (*) Notice: Subject to any disclaimer, the term of this 5,593,838 A 1/1997 Zanzucchi et al. patent is extended or adjusted under 35 5,605,662 A 2f1997 Heller et al. U.S.C. 154(b) by 0 days. 5,620,850 A 4/1997 Bamdad et al. 5,624,711 A 4/1997 Sundberg et al. (21) Appl. No.: 10/865,431 5,627,369 A 5/1997 Vestal et al. 5,629,213 A 5/1997 Kornguth et al. (22) Filed: Jun. 9, 2004 (Continued) (65) Prior Publication Data FOREIGN PATENT DOCUMENTS US 2005/O118665 A1 Jun. 2, 2005 EP 596421 10, 1993 EP 0619321 12/1994 (51) Int. Cl. EP O664452 7, 1995 CI2O 1/50 (2006.01) EP O818467 1, 1998 (52) U.S.
    [Show full text]
  • Synthesis 2-14 Nucleotides Upstream of C2A12(C2-3/T2)
    Proc. Nati. Acad. Sci. USA Vol. 82, pp. 4023-4027, June 1985 Biochemistry Mouse DNA polymerase a-primase terminates and reinitiates DNA synthesis 2-14 nucleotides upstream of C2A12(C2-3/T2) sequences on a minute virus of mice DNA template (primase consensus formula/telomere replication/linear eukaryotic chromosome/discontinuous DNA synthesis) EMANUEL A. FAUST*t, RANDY NAGY*, AND SCOTT K. DAVEY*t *Cancer Research Laboratory and tDepartment of Biochemistry, University of Western Ontario, London, Ontario, N6A 5B7, Canada Communicated by Robert L. Sinsheimer, February 22, 1985 ABSTRACT The distribution of termination and initiation simple viral DNA molecule contains self-complementary sites in a 5081-nucleotide minute virus of mice DNA template sequences, 115 and 206 nucleotides long, at its 3' and 5' being copied by a highly purified mouse DNA polymerase termini, respectively; these regions contain the cis-dominant a-DNA primase complex in the presence of GTP has been genetic elements that comprise the origin for viral DNA examined. The 3'-hydroxyl termini (17 in all) were clustered at replication (14, 15). During the late S or early G2 phase of the six sites that were located 2-14 nucleotides upstream of cell cycle, the viral genome is converted to a double-stranded C2A2C2, C2AC3, or C2A2T2 sequences. When either [a-32p], or replicative form (RF) DNA by cellular enzymes, possibly [y-32P]GTP was included in the DNA polymerase reaction including DNA polymerase a (16). Viral DNA replication mixtures, nascent DNA became radiolabeled. Analysis of the proceeds through linear monomeric and dimeric replicative 32P-labeled material following treatment of the DNA with intermediates (17).
    [Show full text]
  • Ribonuclease Product Highlights
    RIBONUCLEASE Molecular Biology Worthington Ribonucleases A & B are prepared from bovine pancreas and are offered in several grades to suit various applications. When Ribonuclease A is used to remove RNA during DNA isolation, the enzyme must be free of deoxyribonuclease activity to prevent damage to the DNA. Where other enzymes are BSE cover icon BSE used or where the goal is recovery of intact proteins, proteolysis must be prevented. These requirements are satisfied by our Molecular Biology Grade Ribonuclease (Code: RPDF). This and other ribonuclease preparations made by Worthington are described below. Description Activity Code Cat. No. Size Price RNase A, DNase and Protease Free ≥ 2,000 units RPDF LS002131 1 mg $ 22.00 BSE Molecular Biology Grade. Supplied as a per mg protein LS002132 5 mg 69.00 BSE simplied icon for use near interiorsolution text containing approximately 5mg/ml in LS002130 Bulk Inquire Can also be used as a “key” in Table of Contents,50% etc. glycerol. Prepared specifically for use in purifying DNA plasmids. Each lot is assayed to be free of DNase and protease. Store at 2 - 8°C. BSE Storage at –20°C is acceptable. Ribonuclease A, Purified ≥ 3,000 units RAF LS005649 25 mg $ 52.00 A highly purified, lyophilized preparation per mg LS005650 100 mg 160.00 which may contain aggregates as a result of dry weight LS005655 Bulk Inquire lyophilization but which exhibits same specific activity as RASE (below). Store at 2 - 8°C. PRODUCT HIGHLIGHTS PROTECT FROM MOISTURE. Ribonuclease A, Purified Solution ≥ 3,000 units RASE LS005677 25 mg $ 45.00 Monomeric form, purified by method used for per mg protein LS005679 100 mg 110.00 RAF (above) and further processed to remove LS005681 Bulk Inquire aggregates.
    [Show full text]
  • Sequence-Specific Endoribonucleases
    Sequence-specific endoribonucleases ABSTRACT 1 ibonucleases are nucleolytic enzymes that commonly occur in living organisms and Dawid Głów Ract by cleaving RNA molecules. These enzymes are involved in basic cellular process- es, including the RNA maturation that accompanies the formation of functional RNAs, as Martyna Nowacka1 well as RNA degradation that enables removal of defective or dangerous molecules or ones that have already fulfilled their cellular functions. RNA degradation is also one of the main Krzysztof J. Skowronek1, processes that determine the amount of transcripts in the cell and thus it makes an import- ant element of the gene expression regulation system. Ribonucleases can catalyse reactions 1,2, involving RNA molecules containing specific sequences, structures or sequences within a Janusz M. Bujnicki specific structure, they can also cut RNAs non-specifically. In this article, we discuss ribonu- cleases cleaving the phosphodiester bond inside RNA molecules within or close to particular 1Laboratory of Bioinformatics and Protein En- sequences. We also present examples of protein engineering of ribonucleases towards the gineering, International Institute of Molecular development of molecular tools for sequence-specific cleavage of RNA. and Cell Biology in Warsaw, Warsaw, Poland 2Department of Bioinformatics, Institute of INTRODUCTION Molecular Biology and Biotechnology, Facul- ty of Biology, Adam Mickiewicz University, Ribonucleases (RNases) belong to the class of transferases (phosphotrans- Poznan, Poland ferases, EC 2.7), or to the class of hydrolases (esterases, EC 3.1), enzymes that catalyse the hydrolysis of phosphodiester bonds in the ribonucleic acid (RNA). Laboratory of Bioinformatics and Protein RNases can be classified according to the location of the hydrolysed bond in Engineering, International Institute of the RNA polynucleotide chain into: exoribonucleases that cleave the bond con- Molecular and Cell Biology in Warsaw, 4 necting the terminal nucleotide residue in the chain, and endoribonucleases Ks.
    [Show full text]